FOXL2 and cervical cancer: Not only in cervical cancer, Dong et al. reported that the new HMGA2-FOXL2 pathway was involved in the regulation of multiple malignant behaviors in gastric cancer and confirmed that the inhibition of FOXL2 expression impaired cell migratory, invasion potential, and epithelial-to-mesenchymal transition (EMT) [25].